MDC Afternoon for Immunology

We are excited to announce the next session of our MDC Afternoons for Immunology, a quarterly event aimed at bringing together scientists across diverse immunological backgrounds, enhancing networking, and strengthening connections across MDC and Berlin.

This time, we have two fantastic keynote speakers. 

Dr. Jeffrey A. Hubbell, Prof. at the Department of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine. Jeffrey Hubbell develops immunomodulatory biomaterials and engineered proteins to control the immune system in precise, disease-specific ways. His research is highly translational, with multiple technologies commercialized through companies he has founded.

Dr. Stefano Casola, Prof. at the University of Milan, PI at the IFOM ETS – The AIRC Institute of Molecular Oncology. His lab investigates how the antigen receptor on B-cells drives their normal development and how its signaling and associated genetic pathways become corrupted to cause germinal-center derived B-cell lymphomas.
 

Program

14:10–14:30
Clara Marie Barraud 
Suphansa Sawamiphak lab
Max Delbrück Center for Molecular Medicine
Macrophage trafficking contributes to gut-brain crosstalk in hypertension

14:30–14:50
Llorenç Solé Boldo
Simon Haas lab
Max Delbrück Center for Molecular Medicine
Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma

14:50–15:00
Break

15:00–16:00
Jeffrey A. Hubbell
New York University Tandon School of Engineering
Engineering immunological tolerance using antigens, cytokines, and metabolites

16:00–16:30
Coffee break
…with drinks and snacks

16:30–16:50
Andreas Zach
Klaus Rajewsky lab
Max Delbrück Center for Molecular Medicine
Signaling of an autoreactive B cell antigen receptor instructs innate-like B cell fate
determination

16:50–17:10
Ernesto Acevedo Ochoa
Klaus Rajewsky lab
Max Delbrück Center for Molecular Medicine
Mutations in FOXO1 are oncogenic drivers in MYC-dependent lymphomagenesis

17:10–18:10
Prof. Stefano Casola
University of Milan
Group leader at the IFOM ETS - AIRC Institute of Molecular Oncology
When receptor editing turns B cells into aggressive lymphomas

18:10
Social gathering
…a great opportunity to network!

Organizers